Product Dossier
TABRECTA
Product Dossier for TABRECTA (capmatinib hydrochloride, Novartis Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes, AusPAR — compiled by arcimedes.
- Sponsor: Novartis Pharmaceuticals
- Active ingredient: capmatinib hydrochloride
- Therapeutic area: Oncology
- Same area: HIBRUKA
- Same area: SUTENT